HOME
ABOUT
Advisory Council Members
News & Community
340B-AWARE
KEY INITIATIVES
2024 Key Initiatives
2023 Key Initiatives
PHAKE OR PHACT
Driving Federal PBM Reform
Fighting PDAB and the Threat to Drug Access
PDAB Modernization Bill Brief
Supporting Precision Medication
2022 Key Initiatives
Champion CO Consumer Healthcare Rights
Hold Federal Prescription Drug Policies Accountable
2021 Key Initiatives
Battle to Protect Patient Access
IN DEPTH
Can Rebate Reform Help Consumers?
Sharing Negotiated Discounts Could Save Some Patients Almost $1000
Use of Biosimilars The Sleeping Giant of Savings on Biologic Specialty Drugs
Colorado’s Prescription Drug Importation Program Is Not a Solution
Opinion: Drug makers charge hospitals less for some medicines. Consumers aren’t getting the savings
OUTSIDE INSIGHTS
CONTACT US
Menu
HOME
ABOUT
Advisory Council Members
News & Community
340B-AWARE
KEY INITIATIVES
2024 Key Initiatives
2023 Key Initiatives
PHAKE OR PHACT
Driving Federal PBM Reform
Fighting PDAB and the Threat to Drug Access
PDAB Modernization Bill Brief
Supporting Precision Medication
2022 Key Initiatives
Champion CO Consumer Healthcare Rights
Hold Federal Prescription Drug Policies Accountable
2021 Key Initiatives
Battle to Protect Patient Access
IN DEPTH
Can Rebate Reform Help Consumers?
Sharing Negotiated Discounts Could Save Some Patients Almost $1000
Use of Biosimilars The Sleeping Giant of Savings on Biologic Specialty Drugs
Colorado’s Prescription Drug Importation Program Is Not a Solution
Opinion: Drug makers charge hospitals less for some medicines. Consumers aren’t getting the savings
OUTSIDE INSIGHTS
CONTACT US
Click on the image below to view the full report.